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Autosomal recessive deficiency in the caspase recruitment domain containing protein
9 (CARD9) results in susceptibility to fungal infections. In the last decade, infections
associated with CARD9 deficiency are more reported due to the advent of genome
sequencing. The aim of this study was to evaluate the frequency, geographic distribution
and nature of mutations in patients with CARD9 deficiency. We identified 60 patients
with 24 mutations and different fungal infections. The presence of the homozygous
(HMZ) p.Q295X (c.883C > T) and HMZ p.Q289X (c.865C > T) mutations were
associated with an elevated risk of candidiasis (OR: 1.6; 95% CI: 1.18–2.15; p = 0.004)
and dermatophytosis (OR: 1.85; 95% CI: 1.47–2.37; p < 0.001), respectively. The
geographical distribution differed, showing that the main mutations in African patients
were different Asian patients; HMZ p.Q289X (c.865C > T) and HMZ p.Q295X
(c.865C> T) accounted for 75% and 37.9% of the African and Asian cases, respectively.
The spectrum of CARD9 mutations in Asian patients was higher than in African. Asia
is the most populous continent in the world and may have a greater genetic burden
resulting in more patients with severe fungal infections. The presence of a high diversity
of mutations revealing 24 distinct variations among 60 patients emphasize that the
unique genetic alteration in CARD9 gene may be associated with certain geographical
areas.
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Frontiers in Microbiology | www.frontiersin.org 1 October 2018 | Volume 9 | Article 2434
fmicb-09-02434 October 12, 2018 Time: 16:44 # 2
Vaezi et al. Frequency and Geographic Distribution of CARD9 Mutations
INTRODUCTION
Susceptibility to fungal infections in otherwise healthy
individuals with Mendelian disorders are increasingly being
recognized (Vinh, 2011) than before the widespread use of
genome sequencing. Primary immunodeficiencies consist of
various genetic defects that affect the innate and adaptive
immune systems. In addition, evaluation of previously healthy,
fungus infected patients, suspected of having a primary genetic
immunodeficiency may give valuable insights on the role of
specific proteins in the immune system for protection from
these infections (Wang et al., 2014; Corvilain et al., 2018).
Caspase recruitment domain containing protein 9 (CARD9) is
a central regulator of innate immunity that is highly expressed
in neutrophils, macrophages, dendritic cells, and during cell
apoptosis in low-serum conditions (Bertin et al., 2000; Liang
et al., 2015). Mutations in several proteins involved in the
CARD9 signaling protein have been demonstrated to cause
primary immunodeficiencies in humans. These mutations cause
a decreased production of cytokines from innate immune cells,
leading to deficiencies of TH17 and accordingly predispose
patients to severe disseminated infections (Conti and Gaffen,
2015). Severe fungal infections in healthy patients have recently
been reported from a few countries, i.e., Algeria, Brazil, France,
China, Iran, Morocco and Tunisia (Glocker et al., 2009;
Drewniak et al., 2013; Lanternier et al., 2013; Wang et al.,
2014; Grumach et al., 2015) and linked to autosomal recessive
CARD9 deficiency. The species involved in these infections
are Trichophyton violaceum, Trichophyton rubrum, Candida
species, Exophiala species, Phialophora verrucosa, Aspergillus
fumigatus, Prototheca zopfii, and Mucor irregularis. Some of
those etiological agents are plant pathogens, which rarely
have been associated with human infection. Highly diverse
clinical manifestations from cutaneous to disseminated and
progressive infections are observed (Boudghène-Stambouli
and Mérad-Boudia, 1991; Boudghène-Stambouli et al., 1992;
Pruszkowski et al., 1995). Our aim was to evaluate the global
frequency, geographic distribution and nature of mutations
in patients with CARD9 deficiency associated with fungal
infections.
MATERIALS AND METHODS
The review process involved study of existing published
literature of all reported cases with fungal infection due
to CARD9 deficiency. To search the published literature,
Medline database through PubMed, Embase through
Scopus, ISI Web of Science, Science Direct and Google
Scholar were used to explore the published literature
of patients with severe fungal infection and CARD9
deficiency using the key words “caspase recruitment domain
deficiency,” “CARD9 deficiency,” “autosomal recessive CARD9
deficiency,” “primary immunodeficiency,” “mutations,” “fungal
infection” or “invasive fungal diseases,” “candidiasis,” “deep
dermatophytosis,” “disseminated phaeohyphomycosis,” and
“chronic mucocutaneous candidiasis” in different combinations.
A total of 21 relevant articles were found using these key words.
The extracted data were analyzed using R software version
3.4.1. The chi-square test was utilized to evaluate associations
between nominal variables and the p-value was estimated
using the Monte Carlo method. To compare the differential
prevalence of CARD9 mutations and determine differences
in causative agents of fungal infections, odds ratios (ORs)
were used. The significance of all ORs, using a 95% Bayesian
credible interval (CI), was calculated using Bayesian logistic
regression.
RESULTS
The Burden of CARD9 Deficiency Is
Positively Correlated With Fungal
Infection
To analyze the role of CARD9 deficiency in fungal infection,
we reviewed the literature and identified 60 cases until 2018.
The total number of patients with severe fungal infection related
to CARD9 deficiency has been summarized in Tables 1A,B
(Boudghène-Stambouli and Mérad-Boudia, 1989, 1991, 1998;
Pruszkowski et al., 1995; Glocker et al., 2009; Drewniak et al.,
2013; Gavino et al., 2014; Wang et al., 2014; Drummond
et al., 2015; Grumach et al., 2015; Herbst et al., 2015; Jachiet
et al., 2015; Lanternier et al., 2015a,b; Alves de Medeiros
et al., 2016; Gavino et al., 2016; Jones et al., 2016; Rieber
et al., 2016; Yan et al., 2016; Boudghene-Stambouli et al.,
2017; Gavino et al., 2018; Sari et al., 2018; Vaezi et al., 2018;
Wang et al., 2018a,b). The age at the time of diagnosis ranged
from 4 to 91 years (mean 34.3 ± 17.9 years). Since 1989,
a total of 14 countries reported cases of fungal infections
associated with CARD9 deficiency (Figure 1). Although most
cases originate from Algeria (North Africa) [n = 12 (21.1%)],
the majority of cases were from several countries in the Asian
continent (n = 29, 48.3%), with Iran reporting the majority
(n = 10/29, 34.5%). The main fungal infection associated
with CARD9 deficiency was candidiasis (40.3%) followed by
deep dermatophytosis (37.3%), phaeohyphomycosis (16.4%)
and invasive aspergillosis (3.0%). T. violaceum, T. rubrum,
and Trichophyton mentagrophytes were observed as etiological
agents of dermatophytosis. Candida infections were caused
by C. albicans and non-albicans Candida species in 70.8%
and 29.2% of the cases, respectively. P. verrucosa (36.4%)
represented the major species of phaeohyphomycosis and were
only reported from China. Neurological infection (40.5%) was
the predominant clinical presentation in Candida infected
patients followed by chronic mucosal and cutaneous candidiasis
(29.7%). The outcome was recorded in 45 cases and 11 (24.4%)
expired.
Associations Among Mutations of the
CARD9 Gene and Infection Status With
Fungal Pathogens
Overall, 24 different genetic alterations in CARD9 were
described in the 60 patients. Three of those were identified
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most frequently: homozygous (HMZ) p.Q289X (c.865C > T),
HMZ p.Q295X (c.883C > T) and HMZ p.D274fsX60 (c.819-
820insG), which accounted for 25.8%, 17.7%, and 8.1% of
the patients, respectively. Multiple variations in CARD9 were
identified in 8.7% of all cases. The correlation between
mutations and fungal infection is shown in Figure 2. The
presence of the HMZ p.Q295X (c.883C > T) and HMZ
p.Q289X (c.865C > T) mutation was associated with an
elevated risk of candidiasis (OR: 1.6; 95% CI: 1.18–2.15;
p = 0.004) and dermatophytosis (OR: 1.85; 95% CI: 1.47–2.37;
p < 0.001), respectively. Also a strong association was evident
between the presence of HMZ p.D274fsX60 (c.819-820insG)
TABLE 1A | Prevalence of fungal infections, duration of infections and causative pathogens in patients with CARD9 deficiency.
Fungal infection Duration of infection, mean ( ± SD), year Nr of cases (%) Causative agent Nr of cases (%)
Dermatophytosis 37.8 ± 18.7 25 (37.3) Trichophyton rubrum 7 (13.0)
Phaeohyphomycosis 8.5 ± 6.6 11 (16.4) Trichophyton violaceum 8 (14.8)
Invasive aspergillosis − 2 (3.0) Trichophyton mentagrophytes 1 (1.9)
Mucormycosis − 1 (1.5) Candida spp 5 (9.3)
Protothecosis − 1 (1.5) Candida albicans 17 (31.5)
Candidiasis 8.5 ± 10.8 27 (40.3) Candida dubliniensis 1 (1.9)
Mucosal and cutaneous candidiasis 11.5 ± 15.5 11 (29.7) Candida glabrata 1 (1.9)
Neurologic infection 5.3 ± 5.6 15 (40.5) Phialophora verrucosa 4 (7.4)
Chronic candidiasis 6.5 ± 7.7 4 (10.8) Exophiala dermatitidis 1 (1.9)
Osteomyelitis 3.3 ± 0.5 3 (8.1) Exophiala spinifera 2 (3.7)
Endophthalmitis 2.3 ± 1.1 3 (8.1) Aspergillus fumigatus 2 (3.7)
Colitis − 1 (2.7) Corynespora cassiicola 2 (3.7)
Ochroconis musae 1 (1.9)
Mucor irregularis 1 (1.9)
Prototheca zopfii 1 (1.9)
Neurologic infection includes meningoencephalitis, meningitis, and brain abscesses.
TABLE 1B | Overview of patient demographics and mutations.
Condition Nr of cases (%) Mutation Nucleotide change Domain Nr of cases (%)
Age (year) HMZ Q289X c.865C>T CCD 16 (25.8)
<20 16 (26.7) HMZ Q295X c.883C>T CCD 11 (17.7)
21–60 39 (65) HMZ D274fsX60 c.819-820insG CCD 5 (8.1)
>60 5 (8.3) HMZ R70W c.208C>T CARD 4 (6.5)
Male/female 30(50)/30(50) HMZ Y91H c.271T>C CARD 4 (6.5)
Country HTZ L64fsX59 c.191–192insTGCT CARD 3 (4.8)
Algeria 12 (21.1) HMZ R101C c.C301T CARD 2 (3.2)
Angola 1 (1.7) HTZ Q158X c.472C>T CCD 1 (1.6)
Brazil 1 (1.7) HTZ G72S c.214G>A CARD 1 (1.6)
China 9 (15.8) HTZ R373P c.1118G>C CCD 1 (1.6)
Egypt 1 (1.7) HMZ R35Q c.104G>A CARD 1 (1.6)
France 4 (7.0) HMZ R18W c.52C>T CARD 1 (1.6)
Iran 10 (17.5) HMZ E323del c.GAG967-969del CCD 1 (1.6)
Korea 1 (1.7) HMZ R101L c.302G>T CARD 1 (1.6)
Morocco 3 (5.3) HMZ R57H c.170G>A CARD 1 (1.6)
Pakistan 1 (1.7) HMZ M1I c.3G>C CARD 1 (1.6)
Tunisia 4 (7.0) HTZ A380P c.1138G>C CCD 1 (1.6)
Turkey 8 (14.0) HTZ R317R c.951G>A CCD 1 (1.6)
United Kingdom 1 (1.7) HTZ S23X c.68C>A CARD 1 (1.6)
United States 1 (1.7) HMZ V261fs c.781delG CCD 1 (1.6)
HTZ G62fs c.184G>A CARD 1 (1.6)
HTZ G96del36 c.288C>T CARD 1 (1.6)
HTZ T231M c.692C>T CCD 1 (1.6)
HTZ F302del c.905_907delTCT CCD 1 (1.6)
HMZ, homozygous; HTZ, heterozygous; CCD, coiled-coiled domain of CARD9 protein; CARD, CARD domain of CARD9 protein.
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FIGURE 1 | The worldwide distributions of fungal infection cases with CARD9 deficiency.
FIGURE 2 | Relation between the types of mutations and different clinical forms. Thick, short, and bold line indicates more reported cases with a mutation and
clinical form; and less cases shown with thin and lane lines.
and disseminated phaeohyphomycosis; 2.42 (95% CI 1.84–3.2,
p < 0.001). This study demonstrated that the HMZ p.Q289X
(c.865C > T) mutation had a more than two-fold increased risk
of dermatophytosis compared with HMZ p.Q295X (c.883C> T),
p < 0.001. Similarly, HMZ p.Q295X (c.883C > T) alteration
increased by two times the risk of developing candidiasis [OR:
1.95 (95% CI 1.42-2.69, p < 0·001)] versus dermatophytosis
(Table 2). T. violaceum infected patients carried a marginally
higher frequency of HMZ p.Q289X (c.865C > T) compared to
non-T. violaceum dermatophytosis cases (43 vs. 56%).
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A Relationship Between CARD9 Gene
Mutations and Specific Geographic
Distribution
The pattern of distribution was differed by geographical region
in reported cases with CARD9 mutations. The main mutations
in African patients were different from those in Asians;
HMZ p.Q289X (c.865C > T) and HMZ p.R101C (c.C301T),
accounting for 75% and 10%, respectively, were the common
mutations in Africa. The three most common mutations in
Asia were HMZ p.Q295X (c.883C > T), HMZ p.D274fsX60
(c.819-820insG), and HMZ p.R70W (c.208C > T), which
accounted for 34.5%, 17.2%, and 13.8% of the Asian cases,
respectively. Notably, HMZ p.Q289X (c.865C > T) was the
most common mutation observed in 75% of the Algerian
patients (9 out of 12), while the HMZ p.Q295X (c.883C > T)
mutation was reported in 8 out of 10 Iranian patients
(80%). This finding is important as it provides a relationship
between mutation and specific geographic occurrence in these
patients.
DISCUSSION
CARD9 deficiency is inherited in an autosomal recessive
manner. CARD9 plays an important role in the activation of
antifungal mechanisms leading to expression of gene products
that initiate the inflammatory cascade (Liang et al., 2015;
Drummond and Lionakis, 2016). The importance of the CARD9
signaling protein in host defense has been demonstrated in a
murine CARD9−/− model with targeted disruptions of innate
signaling from the antifungal pattern-recognition receptor,
dectin-1, that identifies the β-glucan component of the fungal
cell (Taylor et al., 2007). Defective antifungal clearance and
latently infected cells could be the result of impaired CARD9
function (Yamamoto et al., 2014; Drummond and Lionakis,
2016). We analyzed the characteristics, distribution, frequency,
and relationship between the genotype of the CARD9 gene
mutations and fungal infections among the reported cases. Since
the first mutation described in 1989 from Algeria (Boudghène-
Stambouli and Mérad-Boudia, 1989), several mutations have
been reported from Africa. However, only few reports are
from Europe and America. Glocker et al. (2009), reported
a novel CARD9 mutation, HMZ p.Q289X (c.883C > T), in
seven Iranian patients. In this review, the spectrum of CARD9
mutations in Asian patients is higher than in African patients.
So far, more than 24 mutations in the CARD9 gene have
been reported associated with severe fungal infections. Among
these mutations, HMZ p.Q289X (c.865C > T) was the most
common, indicating it is a hot spot in Africa. Infections caused
by T. violaceum and C. albicans dominate, but frequency
differ by region. We found a remarkably low prevalence of
dermatophyte infection in Asian CARD9 deficiency patients.
However, we demonstrate that Candida species infection is
also uncommon in African patients. Our review showed that
the two mutations [HMZ p.Q289X (c.865C > T) and HMZ
p.Q295X (c.883C > T)] are present in 44.3% of the patients.
Dermatophytosis due to the HMZ p.Q289X (c.865C > T)
mutation encompass 75% of African cases and 34.5% of
Asian patients have candidiasis associated with HMZ p.Q295X
(c.883C > T). However, mutations such as HMZ p.R57H
(c.170G > A), heterozygous (HTZ) p.A380P (c.1138G > C) and
HMZ p.R70W (c.208C > T) are only found in the United States,
United Kingdom, and Turkey, respectively, which suggests
that mutations may be specific in particular populations or
geographic regions. Another possible explanation is the high
rate of consanguinity in many closed groups. Although this
autosomal recessive disorder which is rare on a world-wide
scale, it may not be rare in some countries. The variations in
the gene, which are associated with a specific fungal infection,
remain unknown. Asia is the most populous continent in the
world and may have a greater genetic burden resulting in
more patients with severe fungal infections. Although we cannot
exclude other causative factors, our data support the notion
that some CARD9 mutations, circulating in specific geographic
regions, could be the contributing factor for fungal infections.
However, because of the small sample size, future screening
should be conducted to confirm these conclusions. Studying
the impact of genetic variation on severe fungal infection
will improve our understanding of pathogenesis and may
ultimately aid future interventions. CARD9 deficiency should
be considered in patients with unexplained progressive fungal
infection, as it may allow early initiation of appropriate antifungal
treatment. Regular medical follow-up and identification of
patients with CARD9 deficiencies is recommended including
family members.
CONCLUSION
In recent years, interest in primary immunodeficiency
disorders and opportunistic infections has grown.
The current study reviewed 60 reported cases with
CARD9 mutations and severe fungal infections, which
may provide more information about the relationship
between these mutations, the specific geographic presence
and the unique predisposition to a particular fungal
disease.
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